Bicillin C-r 900/300 Injection, Suspension
Product Images NDC 60793-602

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bicillin C-r 900/300 (NDC 60793-602). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemstructure 1 (Bicillin 01)

Chemstructure 1 (Bicillin 01)
Chemical structure diagram of penicillin G benzathine and penicillin G procaine, showing the molecular arrangement of these active ingredients as depicted in the product data for BICILLIN C-R 900/300 injection suspension.*
FDA Label Image

Chemstructure 2 (Bicillin 02)

Chemstructure 2 (Bicillin 02)
Chemical structure diagram of the active ingredients penicillin G benzathine and penicillin G procaine shown as part of BICILLIN C-R 900/300.*
FDA Label Image

Logo (Bicillin 03)

Logo (Bicillin 03)
Label from Pfizer Laboratories Div Pfizer Inc for BICILLIN C-R 900/300 injection suspension, specifying distribution by Pfizer Inc in New York, NY. The label includes the Pfizer logo and indicates the product is an injectable formulation.*
FDA Label Image

Principal Display Panel (2 mL Syringe Label)

Principal Display Panel (2 mL Syringe Label)
Label for BICILLIN C-R 900/300 injection, suspension, containing 900,000 units penicillin G benzathine and 300,000 units penicillin G procaine per 2 mL. The label emphasizes use for deep intramuscular injection only and warns it is fatal if given by other routes. Distributed by Pfizer Inc, New York, NY.*
FDA Label Image

Principal Display Panel (2 mL Syringe Carton)

Principal Display Panel (2 mL Syringe Carton)
Packaging label for Bicillin C-R 900/300, an injectable suspension containing penicillin G benzathine and penicillin G procaine with a strength of 1,200,000 units per 2 mL. The label specifies intramuscular use, pediatric indication, and includes warnings about route of administration. The product is distributed by Pfizer Laboratories Div Pfizer Inc and is presented as ten syringes of 2 mL size each. Additional details include the presence of a 21 gauge, thin-wall, 1 inch needle for pediatric use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.